| LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy P Li, Q Li, N Biswas, H Xin, T Diemer, L Liu, L Perez Gutierrez, ... EMBO molecular medicine 14 (1), e14511, 2022 | 11 | 2022 |
| Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders H Xin, N Biswas, P Li, C Zhong, TC Chan, E Nudleman, N Ferrara Proceedings of the National Academy of Sciences 118 (21), 2021 | 17 | 2021 |
| Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells W Liang, N Ferrara Frontiers in Immunology, 3919, 2021 | 36 | 2021 |
| Comberons from single cell transcriptomics in endothelial cells S Domanskyi, A Hakansson, M Meng, JSG Zivin, C Piermarocchi, ... bioRxiv, 2021 | 4* | 2021 |
| Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways C Zhong, P Li, S Argade, L Liu, A Chilla, W Liang, H Xin, B Eliceiri, ... Nature communications 11 (1), 1-21, 2020 | 24 | 2020 |
| Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents N Ferrara US Patent App. 16/962,529, 2020 | | 2020 |
| " anticorpo anti-bv8, anticorpo, ácido nucleico, vetor, composição, método para produzir um anticorpo anti-bv8 e usos de um anticorpo Y Wu, J Tien, L Yu, N Ferrara, WC Liang, X Wu, YJG Meng | | 2020 |
| Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer Y Itatani, T Yamamoto, C Zhong, AA Molinolo, J Ruppel, P Hegde, ... Proceedings of the National Academy of Sciences 117 (35), 21598-21608, 2020 | 58 | 2020 |
| Tipifarnib as a precision therapy for HRAS-mutant head and neck squamous cell carcinomas M Gilardi, Z Wang, M Proietto, A Chillà, JL Calleja-Valera, Y Goto, ... Molecular cancer therapeutics 19 (9), 1784-1796, 2020 | 93 | 2020 |
| Blockade of IL17-GCSF-Bv8 inflammation axis ameliorate resistant to anti-angiogenic therapy for colon cancer Y Itatani, T Yamamoto, N Ferrara Cancer Research 80 (16 Supplement), 1475-1475, 2020 | | 2020 |
| Interleukin-22 promotes tumor angiogenesis NJ Protopsaltis, W Liang, E Nudleman, N Ferrara Angiogenesis 22 (2), 311-323, 2019 | 75 | 2019 |
| VEGF in signaling and disease: beyond discovery and development RS Apte, DS Chen, N Ferrara Cell 176 (6), 1248-1264, 2019 | 1933 | 2019 |
| The role of the vegf signaling pathway in tumor angiogenesis N Ferrara Tumor Angiogenesis: A Key Target for Cancer Therapy, 211-226, 2019 | 17 | 2019 |
| Metastatic growth instructed by neutrophil-derived transferrin W Liang, Q Li, N Ferrara Proceedings of the National Academy of Sciences 115 (43), 11060-11065, 2018 | 60 | 2018 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21 (3), 425-532, 2018 | 574 | 2018 |
| Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors N Ferrara, N Korsisaari, RD Mass US Patent App. 15/677,804, 2018 | 3 | 2018 |
| Endothelial cell specific gene expression changes in Oxygen Induced Retinopathy (OIR) A Bartakova, G Weiner, M Oldham, N Ferrara, R Daneman, E Nudleman Investigative Ophthalmology & Visual Science 59 (9), 5470-5470, 2018 | 1 | 2018 |
| Introduction by the Guest Editors: Bevacizumab N Ferrara, DS Chen The Cancer Journal 24 (4), 163-164, 2018 | | 2018 |
| The prokineticins: neuromodulators and mediators of inflammation and myeloid cell-dependent angiogenesis L Negri, N Ferrara Physiological reviews 98 (2), 1055-1082, 2018 | 76 | 2018 |
| Inhibitors of angiopoietin-like 4 protein, combinations, and their use N Ferrara, HP Gerber, XH Liang | | 2017 |
